Last reviewed · How we verify
Placebo (for alirocumab)
Placebo (for alirocumab) is a Small molecule drug developed by Sanofi. It is currently in Phase 3 development for Hyperlipidemia.
Placebo does not have a pharmacological effect.
Placebo does not have a pharmacological effect. Used for Hyperlipidemia.
At a glance
| Generic name | Placebo (for alirocumab) |
|---|---|
| Sponsor | Sanofi |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
A placebo is a dummy treatment that has no therapeutic effect. It is used as a control in clinical trials to compare the efficacy of active treatments.
Approved indications
- Hyperlipidemia
Common side effects
- Injection site reaction
- Musculoskeletal pain
- Fatigue
Key clinical trials
- Cardiac Allograft Vasculopathy Inhibition With Alirocumab (PHASE2)
- Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study) (PHASE3)
- Alirocumab in Patients with Sepsis (PHASE1)
- Efficacy and Safety Of Alirocumab to Prevent Early Cardiac Allograft Vasculopathy in Recent Heart Transplant Recipients (PHASE4)
- INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers (NA)
- An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (PHASE3)
- Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia (PHASE2)
- Effect of Alirocumab on Postprandial Hyperlipemia in Patients With Type 2 Diabetes (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo (for alirocumab) CI brief — competitive landscape report
- Placebo (for alirocumab) updates RSS · CI watch RSS
- Sanofi portfolio CI
Frequently asked questions about Placebo (for alirocumab)
What is Placebo (for alirocumab)?
How does Placebo (for alirocumab) work?
What is Placebo (for alirocumab) used for?
Who makes Placebo (for alirocumab)?
What development phase is Placebo (for alirocumab) in?
What are the side effects of Placebo (for alirocumab)?
Related
- Manufacturer: Sanofi — full pipeline
- Indication: Drugs for Hyperlipidemia
- Compare: Placebo (for alirocumab) vs similar drugs
- Pricing: Placebo (for alirocumab) cost, discount & access